The molecular mechanism of ginsenoside Rh2 and its octyl ester derivative on anti-angiogenesis in cancer treatment: The battle between PI3K and ROS

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 90dcb1e9bb71228b-LAX IP: 47.97.18.252 UTC time: 2025-02-06T17:00:11+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4